The application of PROTACs in immune-inflammation diseases

Chao Zhang(Shanghai Sunshine Rehabilitation Center), Yu Rao(Soochow University), Peilu Song(Tsinghua University), Xiuyun Sun(Tsinghua University)
Bioorganic & Medicinal Chemistry
October 28, 2024
10.1016/j.bmc.2024.117967
Cited by 10

Related Papers

PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
|Nature|2012|488
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270